Global Herceptin Biosimilar Industry Research Report 2020, Forecast to 2025

June 2020 | 106 pages | ID: GE7B2FA7FE27EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Herceptin Biosimilar market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Herceptin Biosimilar is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Herceptin Biosimilar industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Herceptin Biosimilar by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Herceptin Biosimilar market are discussed.

The market is segmented by types:

• Breast Cancer
• Colorectal Cancer
• Leukemia
• Lymphoma
• Other

It can be also divided by applications:

• Hospital & Clinics
• Oncology Centers
• Other

And this report covers the historical situation, present status and the future prospects of the global Herceptin Biosimilar market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Amgen
• Mylan
• Celltrion
• AryoGen Biopharma
• Mabion
• Biocon
• The Instituto Vital Brazil
• Genor Biopharma
• Gedeon Richter
• Roche

Report Includes:

• xx data tables and xx additional tables
• An overview of global Herceptin Biosimilar market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Herceptin Biosimilar market
• Profiles of major players in the industry, including%li% Amgen, Mylan, Celltrion, AryoGen Biopharma, Mabion.....

Research objectives

• To study and analyze the global Herceptin Biosimilar consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Herceptin Biosimilar market by identifying its various subsegments.
• Focuses on the key global Herceptin Biosimilar manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Herceptin Biosimilar with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Herceptin Biosimilar submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Herceptin Biosimilar Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Herceptin Biosimilar Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 HERCEPTIN BIOSIMILAR INDUSTRY OVERVIEW

2.1 Global Herceptin Biosimilar Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Herceptin Biosimilar Global Import Market Analysis
  2.1.2 Herceptin Biosimilar Global Export Market Analysis
  2.1.3 Herceptin Biosimilar Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Breast Cancer
  2.2.2 Colorectal Cancer
  2.2.3 Leukemia
  2.2.4 Lymphoma
  2.2.5 Other
2.3 Market Analysis by Application
  2.3.1 Hospital & Clinics
  2.3.2 Oncology Centers
  2.3.3 Other
2.4 Global Herceptin Biosimilar Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Herceptin Biosimilar Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Herceptin Biosimilar Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Herceptin Biosimilar Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Herceptin Biosimilar Manufacturer Market Share
  2.4.5 Top 10 Herceptin Biosimilar Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Herceptin Biosimilar Market
  2.4.7 Key Manufacturers Herceptin Biosimilar Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Herceptin Biosimilar Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Herceptin Biosimilar Industry Impact
  2.7.1 How the Covid-19 is Affecting the Herceptin Biosimilar Industry
  2.7.2 Herceptin Biosimilar Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Herceptin Biosimilar Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Herceptin Biosimilar Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL HERCEPTIN BIOSIMILAR MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Herceptin Biosimilar Sales Market Share by Region
4.2 Global Herceptin Biosimilar Revenue Market Share by Region (2015-2019)
4.3 Global Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Herceptin Biosimilar Market Size Detail
  4.4.1 North America Herceptin Biosimilar Sales Growth Rate (2015-2020)
  4.4.2 North America Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Herceptin Biosimilar Market Size Detail
  4.5.1 Europe Herceptin Biosimilar Sales Growth Rate (2015-2020)
  4.5.2 Europe Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Herceptin Biosimilar Market Size Detail
  4.6.1 Japan Herceptin Biosimilar Sales Growth Rate (2015-2020)
  4.6.2 Japan Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Herceptin Biosimilar Market Size Detail
  4.7.1 China Herceptin Biosimilar Sales Growth Rate (2015-2020)
  4.7.2 China Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL HERCEPTIN BIOSIMILAR MARKET SEGMENT BY TYPE

5.1 Global Herceptin Biosimilar Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Herceptin Biosimilar Sales and Market Share by Type (2015-2020)
  5.1.2 Global Herceptin Biosimilar Revenue and Market Share by Type (2015-2020)
5.2 Breast Cancer Sales Growth Rate and Price
  5.2.1 Global Breast Cancer Sales Growth Rate (2015-2020)
  5.2.2 Global Breast Cancer Price (2015-2020)
5.3 Colorectal Cancer Sales Growth Rate and Price
  5.3.1 Global Colorectal Cancer Sales Growth Rate (2015-2020)
  5.3.2 Global Colorectal Cancer Price (2015-2020)
5.4 Leukemia Sales Growth Rate and Price
  5.4.1 Global Leukemia Sales Growth Rate (2015-2020)
  5.4.2 Global Leukemia Price (2015-2020)
5.5 Lymphoma Sales Growth Rate and Price
  5.5.1 Global Lymphoma Sales Growth Rate (2015-2020)
  5.5.2 Global Lymphoma Price (2015-2020)
5.6 Other Sales Growth Rate and Price
  5.6.1 Global Other Sales Growth Rate (2015-2020)
  5.6.2 Global Other Price (2015-2020)

6 GLOBAL HERCEPTIN BIOSIMILAR MARKET SEGMENT BY APPLICATION

6.1 Global Herceptin BiosimilarSales Market Share by Application (2015-2020)
6.2 Hospital & Clinics Sales Growth Rate (2015-2020)
6.3 Oncology Centers Sales Growth Rate (2015-2020)
6.4 Other Sales Growth Rate (2015-2020)

7 GLOBAL HERCEPTIN BIOSIMILAR MARKET FORECAST

7.1 Global Herceptin Biosimilar Sales, Revenue Forecast
  7.1.1 Global Herceptin Biosimilar Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Herceptin Biosimilar Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Herceptin Biosimilar Price and Trend Forecast (2020-2025)
7.2 Global Herceptin Biosimilar Sales Forecast by Region (2020-2025)
  7.2.1 North America Herceptin Biosimilar Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Herceptin Biosimilar Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Herceptin Biosimilar Production, Revenue Forecast (2020-2025)
  7.2.4 China Herceptin Biosimilar Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF HERCEPTIN BIOSIMILAR INDUSTRY KEY MANUFACTURERS

8.1 Amgen
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Amgen Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Amgen News
8.2 Mylan
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Mylan Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Mylan News
8.3 Celltrion
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Celltrion Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Celltrion News
8.4 AryoGen Biopharma
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 AryoGen Biopharma Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 AryoGen Biopharma News
8.5 Mabion
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Mabion Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Mabion News
8.6 Biocon
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Biocon Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Biocon News
8.7 The Instituto Vital Brazil
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 The Instituto Vital Brazil Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 The Instituto Vital Brazil News
8.8 Genor Biopharma
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Genor Biopharma Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Genor Biopharma News
8.9 Gedeon Richter
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 Gedeon Richter Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 Gedeon Richter News
8.10 Roche
  8.10.1 Company Details
  8.10.2 Product Information
  8.10.3 Roche Herceptin Biosimilar Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.10.4 Main Business Overview
  8.10.5 Roche News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Herceptin Biosimilar Picture
Figure Research Programs/Design for This Report
Figure Global Herceptin Biosimilar Market by Regions (2019)
Table Global Market Herceptin Biosimilar Comparison by Regions (M USD) 2019-2025
Table Global Herceptin Biosimilar Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Herceptin Biosimilar by Type in 2019
Figure Breast Cancer Picture
Figure Colorectal Cancer Picture
Figure Leukemia Picture
Figure Lymphoma Picture
Figure Other Picture
Table Global Herceptin Biosimilar Sales by Application (2019-2025)
Figure Global Herceptin Biosimilar Sales Market Share by Application in 2019
Figure Hospital & Clinics Picture
Figure Oncology Centers Picture
Figure Other Picture
Table Global Herceptin Biosimilar Sales by Manufacturer (2018-2020)
Figure Global Herceptin Biosimilar Sales Market Share by Manufacturer in 2019
Table Global Herceptin Biosimilar Revenue by Manufacturer (2018-2020)
Figure Global Herceptin Biosimilar Revenue Market Share by Manufacturer in 2019
Table Global Herceptin Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Herceptin Biosimilar Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Herceptin Biosimilar Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Herceptin Biosimilar Market
Table Key Manufacturers Herceptin Biosimilar Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Herceptin Biosimilar
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Herceptin Biosimilar Sales (K Units) by Region (2015-2020)
Table Global Herceptin Biosimilar Sales Market Share by Region (2015-2019)
Figure Global Herceptin Biosimilar Sales Market Share by Region (2015-2019)
Figure Global Herceptin Biosimilar Sales Market Share by Region in 2018
Table Global Herceptin Biosimilar Revenue (Million US$) by Region (2015-2020)
Table Global Herceptin Biosimilar Revenue Market Share by Region (2015-2020)
Figure Global Herceptin Biosimilar Revenue Market Share by Region (2015-2020)
Figure Global Herceptin Biosimilar Revenue Market Share by Region in 2019
Table Global Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Herceptin Biosimilar Sales (K Units) Growth Rate (2015-2020)
Table North America Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Herceptin Biosimilar Sales (K Units) Growth Rate (2015-2020)
Table Europe Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Herceptin Biosimilar Sales (K Units) Growth Rate (2015-2020)
Table Japan Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Herceptin Biosimilar Sales (K Units) Growth Rate (2015-2020)
Table China Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Herceptin Biosimilar Sales by Type (2015-2020)
Table Global Herceptin Biosimilar Sales Market Share by Type (2015-2020)
Figure Global Herceptin Biosimilar Sales Market Share by Type in 2019
Table Global Herceptin Biosimilar Revenue by Type (2015-2020)
Table Global Herceptin Biosimilar Revenue Market Share by Type (2015-2020)
Figure Global Herceptin Biosimilar Revenue Market Share by Type in 2019
Figure Global Breast Cancer Sales Growth Rate (2015-2020)
Figure Global Breast Cancer Price (2015-2020)
Figure Global Colorectal Cancer Sales Growth Rate (2015-2020)
Figure Global Colorectal Cancer Price (2015-2020)
Figure Global Leukemia Sales Growth Rate (2015-2020)
Figure Global Leukemia Price (2015-2020)
Figure Global Lymphoma Sales Growth Rate (2015-2020)
Figure Global Lymphoma Price (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global Other Price (2015-2020)
Table Global Herceptin Biosimilar Sales by Application (2015-2020)
Table Global Herceptin Biosimilar Sales Market Share by Application (2015-2020)
Figure Global Herceptin Biosimilar Sales Market Share by Application in 2019
Figure Global Hospital & Clinics Sales Growth Rate (2015-2020)
Figure Global Oncology Centers Sales Growth Rate (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global Herceptin Biosimilar Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Herceptin Biosimilar Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Herceptin Biosimilar Price and Trend Forecast (2020-2025)
Table Global Herceptin Biosimilar Sales (K Units) Forecast by Region (2020-2025)
Figure Global Herceptin Biosimilar Production Market Share Forecast by Region (2020-2025)
Figure North America Herceptin Biosimilar Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Herceptin Biosimilar Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Herceptin Biosimilar Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Herceptin Biosimilar Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Herceptin Biosimilar Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Herceptin Biosimilar Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Herceptin Biosimilar Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Herceptin Biosimilar Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Amgen Company Profile
Figure Herceptin Biosimilar Product Picture and Specifications of Amgen
Table Herceptin Biosimilar Production, Price, Revenue and Gross Margin of 2018-2020
Figure Amgen Herceptin Biosimilar Market Share (2018-2020)
Table Amgen Main Business
Table Amgen Recent Development
Table Mylan Company Profile
Figure Herceptin Biosimilar Product Picture and Specifications of Mylan
Table Herceptin Biosimilar Production, Price, Revenue and Gross Margin of 2018-2020
Figure Mylan Herceptin Biosimilar Market Share (2018-2020)
Table Mylan Main Business
Table Mylan Recent Development
Table Celltrion Company Profile
Figure Herceptin Biosimilar Product Picture and Specifications of Celltrion
Table Herceptin Biosimilar Production, Price, Revenue and Gross Margin of 2018-2020
Figure Celltrion Herceptin Biosimilar Market Share (2018-2020)
Table Celltrion Main Business
Table Celltrion Recent Development
Table AryoGen Biopharma Company Profile
Figure Herceptin Biosimilar Product Picture and Specifications of AryoGen Biopharma
Table Herceptin Biosimilar Production, Price, Revenue and Gross Margin of 2018-2020
Figure AryoGen Biopharma Herceptin Biosimilar Market Share (2018-2020)
Table AryoGen Biopharma Main Business
Table AryoGen Biopharma Recent Development
Table Mabion Company Profile
Figure Herceptin Biosimilar Product Picture and Specifications of Mabion
Table Herceptin Biosimilar Production, Price, Revenue and Gross Margin of 2018-2020
Figure Mabion Herceptin Biosimilar Market Share (2018-2020)
Table Mabion Main Business
Table Mabion Recent Development
Table Biocon Company Profile
Figure Herceptin Biosimilar Product Picture and Specifications of Biocon
Table Herceptin Biosimilar Production, Price, Revenue and Gross Margin of 2018-2020
Figure Biocon Herceptin Biosimilar Market Share (2018-2020)
Table Biocon Main Business
Table Biocon Recent Development
Table The Instituto Vital Brazil Company Profile
Figure Herceptin Biosimilar Product Picture and Specifications of The Instituto Vital Brazil
Table Herceptin Biosimilar Production, Price, Revenue and Gross Margin of 2018-2020
Figure The Instituto Vital Brazil Herceptin Biosimilar Market Share (2018-2020)
Table The Instituto Vital Brazil Main Business
Table The Instituto Vital Brazil Recent Development
Table Genor Biopharma Company Profile
Figure Herceptin Biosimilar Product Picture and Specifications of Genor Biopharma
Table Herceptin Biosimilar Production, Price, Revenue and Gross Margin of 2018-2020
Figure Genor Biopharma Herceptin Biosimilar Market Share (2018-2020)
Table Genor Biopharma Main Business
Table Genor Biopharma Recent Development
Table Gedeon Richter Company Profile
Figure Herceptin Biosimilar Product Picture and Specifications of Gedeon Richter
Table Herceptin Biosimilar Production, Price, Revenue and Gross Margin of 2018-2020
Figure Gedeon Richter Herceptin Biosimilar Market Share (2018-2020)
Table Gedeon Richter Main Business
Table Gedeon Richter Recent Development
Table Roche Company Profile
Figure Herceptin Biosimilar Product Picture and Specifications of Roche
Table Herceptin Biosimilar Production, Price, Revenue and Gross Margin of 2018-2020
Figure Roche Herceptin Biosimilar Market Share (2018-2020)
Table Roche Main Business
Table Roche Recent Development
Table of Appendix